Ashley Cordova is CFO at NovoCure Ltd (NVCR). They have made 19 open-market trades across 1 company since 2020, most recently 2026-03-04.
CIK 0001822014
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $997K since 2025, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVCR | 422,570 | $6.2M |
Shares reported on the most recent Form 4, priced at the 2026-03-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVCR | BUY | 2025-09-05 | 2025-09-08 | $12.22 | $997K | +2.4% | +13.0% | -5.0% |
| NVCR | SELL | 2025-03-03 | 2025-03-04 | $18.54 | $38K | +7.9% | -6.0% | -5.7% |
| NVCR | SELL | 2025-02-27 | 2025-03-03 | $19.80 | $452K | +13.1% | +1.1% | -3.9% |
| NVCR | SELL | 2024-08-02 | 2024-08-05 | $20.14 | $14K | -7.1% | -17.9% | -18.5% |
| NVCR | SELL | 2023-09-01 | 2023-09-05 | $21.82 | $19K | -9.1% | -32.2% | -38.8% |
| NVCR | SELL | 2023-08-02 | 2023-08-04 | $30.25 | $35K | +11.6% | -23.5% | -51.6% |
| NVCR | SELL | 2023-03-03 | 2023-03-07 | $76.16 | $779K | -23.5% | -15.5% | +10.6% |
| NVCR | SELL | 2023-03-02 | 2023-03-06 | $75.28 | $159K | -14.8% | -17.9% | +9.1% |
| NVCR | SELL | 2023-03-01 | 2023-03-02 | $76.36 | $336K | -11.2% | -20.6% | -5.2% |
| NVCR | SELL | 2022-09-02 | 2022-09-06 | $79.04 | $140K | +10.6% | +8.5% | -0.8% |
| NVCR | SELL | 2022-03-08 | 2022-03-09 | $70.10 | $106K | +8.0% | +18.3% | +7.9% |
| NVCR | SELL | 2022-03-03 | 2022-03-07 | $73.70 | $210K | +12.5% | +25.0% | +15.6% |
| NVCR | SELL | 2021-11-02 | 2021-11-03 | $107.28 | $22K | +2.0% | -25.5% | -34.9% |
| NVCR | SELL | 2021-09-02 | 2021-09-07 | $138.23 | $229K | -5.0% | -17.8% | -39.6% |
| NVCR | SELL | 2021-08-12 | 2021-08-16 | $140.94 | $7.5M | -1.3% | -6.1% | -16.7% |
| NVCR | SELL | 2021-03-08 | 2021-03-10 | $130.81 | $200K | +6.1% | -0.1% | +58.8% |
| NVCR | SELL | 2021-03-04 | 2021-03-08 | $137.55 | $156K | +5.1% | +0.5% | +59.8% |
| NVCR | SELL | 2021-03-02 | 2021-03-04 | $152.05 | $130K | +8.8% | -0.9% | +55.3% |
| NVCR | SELL | 2020-11-02 | 2020-11-03 | $117.41 | $27K | +6.8% | +15.9% | +39.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.